The TRIUMPH-1 trial enrolled adults with a BMI of 30 or above, or a BMI of at least 27 plus a weight-related health condition
So they dont want distractions. In her view, this means the FDA will move as quickly as it can to resolve the shortages, especially given the incoming administrations links to GLP-1 compounding, which Hunterbrook has reported on in the past
Treat it as non-negotiable as brushing your teeth
But for others, medication is the beginning of the journey, not the end of it
In selected cases, IV nutrition and cellular support therapies may be used to enhance nutrient delivery and support cellular function more efficiently
Weghuber D, Barrett T, Barrientos-Perez M, Gies I, Hesse D, Jeppesen OK, et al